Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2025

Jun 2, 2025

32485_dirs_2025-06-02_ca20e5bc-f7ac-4b86-96c1-fdf32522345c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2025-05-29

Reporting Person: Lotvin Alan (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-29 Director stock option (right to buy) $0.72 A 125862 Acquired 2035-05-29 Class A Ordinary Shares (125862) Direct

Footnotes

F1: These options were granted under the Issuer's non-employee director compensation policy.

F2: The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting.